Follow Us: Follow Prostate on Facebook Follow ProstateNet on Twitter Get the Prostate.net RSS feed

Tag Archives: Risk factors

Can a Prostate Biopsy Give You Prostatitis?

A recent study published in Urology has shown that in patients who undergo transrectal prostate biopsy, prior use of antibiotics is the most significant risk factor for developing post-procedure acute prostatitis. The researchers identified acute prostatitis in 9.3 percent of the patients after prostate biopsy. Prior use of a fluoroquinolone antibiotic was the most significant… Continue Reading »


More about: ,

Mice Exposed to BPA Less Attractive to Females

A growing body of evidence has linked exposure to the chemical BPA (Bisphenol-A) to all manner of illness including prostate cancer and now it seems if you are exposed to BPA (if you are a male mouse that is), then your chances of attracting a female just became a lot worse. Bisphenol A (BPA) is… Continue Reading »


More about: , , , ,

Selenium and Prostate Cancer Risk

New research from the Institute for Transdisciplinary Health Research, in Berlin, casts more doubt over long-established claims made for the powers of selenium. The Cochrane Systematic Review of fifty-five previous studies focused on evidence of links between selenium exposure and cancer risk including prostate cancer. The review of the results of studies led the researchers to conclude that… Continue Reading »


More about: , , , ,

Parkinson’s Disease Linked to Increased Risk for Prostate Cancer

Scientists have been looking at the increased cancer risk in Parkinson’s disease patients for years, particularly skin cancers and melanoma.  Now, University of Utah School of Medicine researchers have found evidence to suggest that the neurological condition is also associated with an increased risk of prostate cancer and that the risk extends to both close… Continue Reading »


More about: , , ,

BPH Drug Dutasteride (Avodart) and Prostate Cancer

Results of a four-year study show that men who took dutasteride (Avodart), a drug commonly prescribed for benign prostatic hyperplasia (BPH), were less likely to be diagnosed with prostate cancer. However, men taking dutasteride who did develop prostate cancer were more likely to have more deadly tumors—those with a high Gleason score—than men who took… Continue Reading »


More about: , , ,

Soda Coloring May Increase Risk of Cancer

If you are a soda drinker, it may be time to rethink your drink.  An advocacy organization has brought to light some studies that indicate that the caramel coloring used in dark soft drinks and some foods are known to be carcinogens in mice and rats.  The Center for Science in the Public Interest is… Continue Reading »


More about: , , ,

Vasectomy and Prostate Cancer Risk

If you undergo a vasectomy, do you increase your risk of getting prostate cancer? This is a question many men think about or ask their doctor. Given that one in six men 35 years and older in the United States have had a vasectomy, the answer has the potential to impact a great number of… Continue Reading »


More about: , , , , ,

Can Doctors “Prevent” Disease?

There’s no question Americans need to stop smoking, eat less junk food and get more exercise. But can physicians — many of whom have little training in nutrition or exercise coaching — succeed in changing patient behaviors? And on top of that, can the current “business of medicine” support the additional time and attention needed… Continue Reading »


More about: , , , , ,

Vitamin E – The Good and The Bad for Prostate Health

Vitamin E is a powerful antioxidant whose main tasks are to fight free radical production and activity and to help with immune system functioning, cell signaling, and metabolism. The form of vitamin E used in most studies and found in most supplements is alpha-tocopherol. However, recent research has shown that gamma-tocopherol may help fight prostate… Continue Reading »


More about: , ,

Five Year Outcomes Published on CyberKnife Radiosurgery for Prostate Cancer

The multi-center study, published in the January 10, 2011 issue of Radiation Oncology, found that 93 percent of patients had no recurrence of their cancer at a median follow-up of five years, a rate that compares favorably to results obtained with other treatment modalities, including surgery and conventional radiation therapy. Read more


More about: , ,

  • Advertisement

  • better300x172rev2bgif
    ADVERTISEMENT

  • Advertisement